P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

September 2013

Features

Prescription Drug Abuse Hits Hospitals Hard

Tighter Federal Steps Aim to Deflate Crisis

Hospitals and their pharmacy departments are now at the epicenter of the prescription drug-abuse tsunami. The Obama administration is using regulatory agencies in an to attempt to crack down on physician-run "pill mills" and the pharmacies that support them.
Stephen Barlas

Identifying Knowledge Gaps in the Labeling of Medications for Geriatric Patients

The authors found that two-thirds of drugs approved by the FDA in recent years lacked adequate efficacy and safety information for use in older patients. With an expected doubling of the elderly population by 2040, it is time for pharmaceutical manufacturers to incorporate more robust prescribing information into their product labels of drugs used in this patient population.
Trevor Hinshaw; Joan Kapusnik-Uner, PharmD; Barbara Zarowitz, PharmD; and Karl Matuszewski, MS, PharmD

Role of Pharmacogenomic Biomarkers in Predicting and Improving Drug Response

Part 1: The Clinical Significance of Pharmacogenetic Variants

As genotyping and genetic testing become more sophisticated, accessible, and cost-effective, these tools hold great promise for predicting and improving responses to medications.
C. Lee Ventola, MS

Controversies in Practice

Prostate Cancer Risk and Omega-3 Fatty Acid Intake From Fish Oil

A Closer Look at Media Messages Versus Research Findings

Although fish and fish oil supplements have been touted for their many benefits, especially in the treatment of cardiovascular disease, recent headlines have suggested that they might be linked to an increased risk of prostate cancer. P&T takes a closer look behind the mixed messages.
Walter Alexander

Departments

Medication Errors

Fatalities After Inadvertent Injections of Topical Epinephrine

Mixups with local and topical epinephrine have led to fatalities.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Proposed Changes in Medicare Hospital Payments Would Affect Pharmacy and Beyond

Drug Companies Push to Rein in 340B Discount Drugs

Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Afatinib (Gilotrif) for non–small-cell lung cancer; golimumab (Simponi Aria) for moderate-to-severe active rheumatoid arthritis; and levomilnacipran (Fetzima) extended release for major depressive disorder
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Lorcaserin (Belviq)

A Selective Serotonin 5-HT2C Agonist in the Treatment of Obesity

Lorcaserin (Belviq) for the treatment of obesity
Ashley Gustafson, PharmD; Camille King, PharmD; and Jose A. Rey, PharmD, BCPP